Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.
Nefrologia (Engl Ed)
; 41(4): 412-416, 2021.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2105644
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Vacunas
/
COVID-19
/
Nefrología
Tipo de estudio:
Estudio pronóstico
Tópicos:
Vacunas
Límite:
Humanos
Idioma:
Inglés
Revista:
Nefrologia (Engl Ed)
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
J.nefroe.2021.09.001
Similares
MEDLINE
...
LILACS
LIS